PATENT CLAIM ANALYSIS

Application Number: 16007671
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "017500"]

Abstract:
The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.

Claim (Index 6):
The method, according to  claim 1 , wherein the salt is selected from the group consisting of acetate salt, aspartate (L) salt, citrate salt, fumarate salt, hippurate salt, hydrochloride salt, lactate salt, malate (L) salt, mucate salt, phosphate salt, sulfate salt, hemi-sulfate salt, tartrate (L) salt, gluconate (D) salt, maleate salt, and succinate salt.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15439813', '13477423', '14354092', '13003761', '14622660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7571622329093379
- 35 USC 102 Novelty (BERT): 0.5066868989850278
- Combined Prediction Score: 0.732114699516907
- Mean Citation Score: 209.60784400000003
- Max Citation Score: 217.47653
- Similarity Product: 124.69368401865006

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test